BioCentury
ARTICLE | Clinical News

Actimab-A regulatory update

January 5, 2015 8:00 AM UTC

FDA granted Orphan Drug designation to Actimab-A from Actinium to treat acute myelogenous leukemia (AML) in patients ages =60. The product -- actinium-225 attached to the anti- CD33 mAb lintuzumab (Hu...